Showing results (1-10 of 427) with videos related to
Sort By:
Pageof 43
Current Drug Safety|April 29, 2011
Vitamin D treatment in primary hyperparathyroidismLars Rolighed, Jens Bollerslev, Leif MosekildeUgeskrift for Laeger|July 16, 2002
[Osteoclast function is regulated by neighbouring osteoblasts. Osteoprotegerin, RAND and RANK ligand constitute a unique regulatory system for bone resorption with important pathophysiological and therapeutic aspects]Thor Ueland, Jens Bollerslev, Leif MosekildeJournal of Internal Medicine|April 6, 2026
Individualized management of primary hyperparathyroidismJens Bollerslev, Filomena Cetani, Neil Gittoes, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|July 21, 2011
The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled studyTanja Sikjaer, Lars Rejnmark, Lars Rolighed, et al.European Journal of Endocrinology|April 5, 2012
Renal stones and calcifications in patients with primary hyperparathyroidism: associations with biochemical variablesJakob Starup-Linde, Elin Waldhauer, Lars Rolighed, et al.The Journal of Clinical Endocrinology and Metabolism|March 12, 2003
Age-related changes in cortical bone content of insulin-like growth factor binding protein (IGFBP)-3, IGFBP-5, osteoprotegerin, and calcium in postmenopausal osteoporosis: a cross-sectional studyThor Ueland, Kim Brixen, Lis Mosekilde, et al.European Journal of Endocrinology|October 4, 2011
Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidismJens Bollerslev, Claudio Marcocci, Manuel Sosa, et al.European Journal of Endocrinology|June 15, 2013
Muscle function and quality of life are not impaired in familial hypocalciuric hypercalcemia: a cross-sectional study on physiological effects of inactivating variants in the calcium-sensing receptor gene (CASR)Niels Frederik Breum Jakobsen, Lars Rolighed, Peter H Nissen, et al.Langenbeck'S Archives of Surgery|November 8, 2012
BMD improvements after operation for primary hyperparathyroidismLars Rolighed, Peter Vestergaard, Lene Heickendorff, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 8, 2013
PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatmentTanja Sikjaer, Anne Kristine Amstrup, Lars Rolighed, et al.Pageof 43